Tissues and organs are procurable from a living or deceased donor. Live donation involves either kidney, partial liver, or lung. The Institute of Medicine - American National Academy of Sciences clarified that a clinician could declare death using either neurologic criteria or circulatory criteria.  Following such determination, select organ(s) may be procured from the donor and then transplanted into a host.
Sadly, every day, patients suffer morbidity or mortality due to a lack of availability of tissue or an organ transplant.  Health professionals are often in a position to encourage families to make the difficult decision at the time of death of their loved one, to give the gift of life to another human, by donating tissues or organs. 
There are numerous challenges to organ donation, especially at a time when the family is grieving. Further, few patients have discussed the issue with their families, as such, they may not be able to anticipate the desires of their passing family member.
Health providers must have the education to address family misconceptions and assist the team in donation recovery, preservation, and placement of tissues and organs from deceased and living donors. By educating practitioners about tissue and organ donation, more families will make the decision to donate and decrease the number of patients that pass due to lack of tissues or organs.
Tissue and organ donation is of tremendous benefit to living patients as it functions to help the living. One individual's tissue and organ donation can impact numerous lives. While the majority of the public is in favor of organ donation, individuals often fail to include this decision in their living wills. Further, while many states allow drivers to register as organ donors on their driver licenses, few complete the required form. The consequence is a tremendous tissue and organ shortage leading to long wait times on transplant lists that in many instances result in premature deaths of viable patients that could have lived longer lives with the benefit of tissue and organ transplants.
Care during the organ donation process is multi-faceted and begins with the optimization of the donor following the determination of death using neurologic or circulatory criteria. This process means optimizing cardiopulmonary status via hemodynamic and ventilatory support. Expeditious organ/tissue procurement is the recommendation because, soon after death, inflammatory mediators begin to invade solid organs leading to increased organ immunogenicity.  While being cautious, from procurement to placement, every step must be done quickly and efficiently to assure the best outcomes.
Healthcare Provider and Team Role
Some health professionals have cultural, ethical, or religious beliefs that preclude their willingness to participate in the donation or receipt of tissues or organs. It is important to respect individuals' personal belief systems; however, personal beliefs should not interfere with the patient's right to self-determination. The primary commitment is to the patient and family. However, certain healthcare professionals may not wish to become involved in the organ and tissue donation process or to participate in campaigns to increase donations in their community and/or facility. This decision should be respected as a personal choice. For those that want to help, the role can be as simple as helping patients make the decision to donate prior to death.
Tissue and organ removal teams' main concerns revolve around permission, removal, and rapid transfer of organs and tissues.  Challenges often involve failure to identify eligible donors, death not officially declared within a specific timeframe, or absence of an appropriate recipient.
Tissue and organ placement teams made concerns include the suitability of the tissue or organ, maintaining the viability of the tissue and organ, and rapid transplantation. Permission issues may stem from the denial of organ donation from a potential donor, donor’s family, or other judicial officers. 
Health professional's responsibilities in tissue and organ donation vary with their role. Some providers work with the families of donors, others with the families of recipients. Some may be responsible for performing surgery and managing the patient. In addition, there is often an administrative team that works with organ procurement organizations. While health professionals should help educate patients on the benefits of organ donation, specific responsibilities of team members include:
Individuals that would like to become involved in tissue and organ donation can do the following steps:
Providers should be aware of the following in regards to tissue and organ procurement and placement:
Tissue and Organ Selection and Processing
Members of the healthcare team should have a clear understanding of the issues involved in tissue and organ donation as this will improve outcomes. Organ donation starts with confirmation of clinical brain death, usually by a neurosurgeon or neurologist. It should be remembered that a coma is not brain death. In general, this is based on accepted medical standards:
Other considerations for death may include family or patient has signed an advanced directive to withdraw life support.
When a prospective donor is near death or has died, the organ procurement coordinator should be notified and informed of the patient's identification number, name, age, past medical history, cause or anticipated cause of death, family contact information, and any other pertinent information. the organ procurement coordinator determines if the patient is a potential donor and should arrive at the hospital within 90 minutes if the patient is a suitable candidate. All deceased patients may be considered for organ donation. The coordinator, if the patient is acceptable, will then speak with the family and gain further information.
If the evaluation rules in donation, the organ procurement coordinator will complete the following:
Tissue and Organ Recovery and Transplantation
Tissues that may be recovered and transplanted include blood vessels, bone, cartilage, corneas, heart valves, skin, and tendons. Organs that may be recovered and transplanted include the heart, intestine, kidney, liver, lung, and pancreas. Steps in the process include:
Following donor optimization, standard organ removal in the operating room is as follows: heart and lungs first, followed by hepatectomy, pancreatectomy, and bilateral nephrectomies.  Subsequent organ cooling to 4 degrees C considerably reduces warm ischemia damage to organs; however, it does not completely arrest cellular processes. Therefore, a thorough organ washout technique, along with selecting appropriate preservation solutions, is critical to organ viability leading to decreased immune reaction and formation of oxygen-free radicals upon reperfusion. 
There are two types of living tissue and organ donation.
While living donation reduces transplant wait times, it has its own set of challenges. The kidney and liver are commonly living donor donations. Less commonly intestines, lung, or pancreas segments are transplanted.
Considerations should be given to cost and potential complications. Living donation requires informed consent due to potential complications. Some are specific to the organ donated. Complications include:
Barriers and Misunderstands Concerning Tissue and Organ Donation
Health professionals should be educated in tissue and organ donation and be prepared to provide families with accurate information while dispelling misunderstandings. 
There are numerous barriers to organ donation and recovery. Health professionals and institutions should provide an experienced team to make the process of tissue and organ donation as efficient as possible while minimizing the emotional impact on donor families. The team often consists of a nurse, a social worker or pastor, and a clinical provider. If the institution provides positive moral and social support, the donation for the family usually proves to be a rewarding experience.
There is a potential cost of living donation. While insurance may cover the surgery and follow-up care, any long-term complications may not necessarily be covered. Uncovered costs include lost wages, particularly if there are long-term complications of surgery. 
Many clinicians and families may have misunderstandings in regards to tissue and organ donation. Examples include a belief that there is an age limit, when in fact there is no age limit on organ donation. Others are concerned it may be a religious violation when in reality few religions prohibit tissue and organ donation. Others are concerned that an open casket may not be possible when this typically is not an issue. Some believe that the health of the donor may prohibit donation, in reality, few medical conditions affect tissue or organ donation. For some donor families, they believe there is a cost associated when no fees are levied. Some even believe the organs are sold, in reality, organs are matched via a computer database which does not consider the financial status of potential recipients. Patients may not agree to donate because they believe health professionals will be less apt to save them in an emergency, when in fact saving their life is the top priority, and tissue and organ donation is not considered. 
Following successful transplantation into a host, the mainstay of long-term care is a combination of lifelong close monitoring and appropriate immunosuppression.  Patients must come to realize that there will never come a time in their lives when close monitoring is no longer necessary. Additionally, clinicians must understand current standard practices in caring for these patients as well as accept upcoming innovations such as monitoring patients for donor-specific antibodies as a marker of immunologic risk.  Furthermore, non-invasive markers found in blood and urine are now beginning to replace biopsies in assessing for immunologic injury. 
Organ donation is vital to patients, yet there is a large deficiency of those willing to donate coupled with a long list of individuals needing tissue and organ donation. By becoming educated regarding the issues and concerns, hopefully, more patients will successfully be encouraged to give the gift of life.
For a successful tissue/organ transplantation to occur, it requires an extraordinary amount of teamwork from all aspects of the healthcare system. Preoperatively, nurses are required to provide close monitoring of hemodynamic parameters outlined in current standard practices and offer interventions as necessary. Intraoperatively, it is known that various specialties of medicine participate in the operation, requiring extensive and clear communication for surgical success. Finally, allied health professionals play a critical role in maximizing the organ recipient’s return to normal function postoperatively, leading to a happy and healthy life.
Communication is a useful tool that is imperative to positive patient outcomes as it relates to organ transplantation. Research participants recognize that nurses are at the center of communication, seeing as they spend the most time at the bedside amongst all healthcare providers.  As such, they become the most powerful means of communicating compliance and good practices to patients during their life-long journey of close monitoring, which involves close screening of infections, organ rejection, and malignancies.
|||Thuong M,Ruiz A,Evrard P,Kuiper M,Boffa C,Akhtar MZ,Neuberger J,Ploeg R, New classification of donation after circulatory death donors definitions and terminology. Transplant international : official journal of the European Society for Organ Transplantation. 2016 Jul; [PubMed PMID: 26991858]|
|||Hollander SA,Nandi D,Bansal N,Godown J,Zafar F,Rosenthal DN,Lorts A,Jeewa A, A coordinated approach to improving pediatric heart transplant waitlist outcomes: A summary of the ACTION November 2019 waitlist outcomes committee meeting. Pediatric transplantation. 2020 Sep 28; [PubMed PMID: 32985785]|
|||Tennankore KK,Gunaratnam L,Suri RS,Yohanna S,Walsh M,Tangri N,Prasad B,Gogan N,Rockwood K,Doucette S,Sills L,Kiberd B,Keough-Ryan T,West K,Vinson A, Frailty and the Kidney Transplant Wait List: Protocol for a Multicenter Prospective Study. Canadian journal of kidney health and disease. 2020; [PubMed PMID: 32963793]|
|||Bakhtiyar SS,Godfrey EL,Ahmed S,Lamba H,Morgan J,Loor G,Civitello A,Cheema FH,Etheridge WB,Goss J,Rana A, Survival on the Heart Transplant Waiting List. JAMA cardiology. 2020 Aug 12; [PubMed PMID: 32785619]|
|||Mahmud N, Selection for Liver Transplantation: Indications and Evaluation. Current hepatology reports. 2020 Jun 19; [PubMed PMID: 32837824]|
|||Todd PM,Jerome RN,Jarquin-Valdivia AA, Organ preservation in a brain dead patient: information support for neurocritical care protocol development. Journal of the Medical Library Association : JMLA. 2007 Jul; [PubMed PMID: 17641753]|
|||Israni AK,Zaun D,Bolch C,Rosendale JD,Snyder JJ,Kasiske BL, Deceased Organ Donation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2016 Jan; [PubMed PMID: 26755269]|
|||Jericho BG, Organ Donation After Circulatory Death: Ethical Issues and International Practices. Anesthesia and analgesia. 2019 Feb; [PubMed PMID: 29787408]|
|||Freeman RB,Bernat JL, Ethical issues in organ transplantation. Progress in cardiovascular diseases. 2012 Nov-Dec; [PubMed PMID: 23217432]|
|||Sandiumenge A,Lomero Martinez MDM,Sánchez Ibáñez J,Seoane Pillado T,Montaña-Carreras X,Molina-Gomez JD,Llauradó-Serra M,Dominguez-Gil B,Masnou N,Bodi M,Pont T, Online education about end-of-life care and the donation process after brain death and circulatory death. Can we influence perception and attitudes in critical care doctors? A prospective study. Transplant international : official journal of the European Society for Organ Transplantation. 2020 Sep 2; [PubMed PMID: 32881149]|
|||Kim K,Lee SH,Kim DH,Lim D,Kang C,Jeong JH,Lee SB,Lee YJ, Effect of a multidisciplinary program to improve organ donation in the emergency department. European journal of emergency medicine : official journal of the European Society for Emergency Medicine. 2020 Sep 23; [PubMed PMID: 32976312]|
|||Paixão JTC,Nascimento VHND,Alves MC,Rodrigues MFA,Sousa EJS,Santos-Lobato BLD, Analysis of brain death declaration process and its impact on organ donation in a reference trauma center. Einstein (Sao Paulo, Brazil). 2020; [PubMed PMID: 32965298]|
|||Frenette AJ,Williamson D,Weiss MJ,Rochwerg B,Ball I,Brindamour D,Serri K,D'Aragon F,Meade MO,Charbonney E, Worldwide management of donors after neurological death: a systematic review and narrative synthesis of guidelines. Canadian journal of anaesthesia = Journal canadien d'anesthesie. 2020 Sep 18; [PubMed PMID: 32949008]|
|||Matar AJ,Wichmann H,Kenney L,Subramanian A,Ratcliff J,Patel V,Tracy BM,Gelbard RB, Outcomes and Implications of a Single Brain Death Exam Policy on Organ Donation Outcomes at a High-volume Trauma Center. The journal of trauma and acute care surgery. 2020 Aug 11; [PubMed PMID: 32796440]|
|||Young PJ,Matta BF, Anaesthesia for organ donation in the brainstem dead--why bother? Anaesthesia. 2000 Feb; [PubMed PMID: 10651668]|
|||Hicks M,Hing A,Gao L,Ryan J,Macdonald PS, Organ preservation. Methods in molecular biology (Clifton, N.J.). 2006; [PubMed PMID: 16790859]|
|||Da Silva IR,Frontera JA, Worldwide barriers to organ donation. JAMA neurology. 2015 Jan; [PubMed PMID: 25402335]|
|||Sharma V,Roy R,Piscoran O,Summers A,van Dellen D,Augustine T, Living donor kidney transplantation: Let's talk about it. Clinical medicine (London, England). 2020 May; [PubMed PMID: 32414729]|
|||Mathur AK,Stewart Lewis ZA,Warren PH,Walters MC,Gifford KA,Xing J,Goodrich NP,Bennett R,Brownson A,Ellefson J,Felan G,Gray B,Hays RE,Klein-Glover C,Lagreco S,Metzler N,Provencher K,Walz E,Warmke K,Merion RM,Ojo AO, Best practices to optimize utilization of the National Living Donor Assistance Center for the financial assistance of living organ donors. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2020 Jan; [PubMed PMID: 31680449]|
|||Kuypers DR,Le Meur Y,Cantarovich M,Tredger MJ,Tett SE,Cattaneo D,Tönshoff B,Holt DW,Chapman J,Gelder Tv, Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation. Clinical journal of the American Society of Nephrology : CJASN. 2010 Feb; [PubMed PMID: 20056756]|
|||Shihab F,Christians U,Smith L,Wellen JR,Kaplan B, Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes. Transplant immunology. 2014 Jun; [PubMed PMID: 24861504]|
|||Gaston RS, IMPROVING LONG-TERM OUTCOMES IN KIDNEY TRANSPLANTATION: TOWARDS A NEW PARADIGM OF POST-TRANSPLANT CARE IN THE UNITED STATES. Transactions of the American Clinical and Climatological Association. 2016; [PubMed PMID: 28066070]|
|||Lefaucheur C,Loupy A,Zeevi A, Complement-binding anti-HLA antibodies and kidney transplantation. The New England journal of medicine. 2014 Jan 2; [PubMed PMID: 24382075]|
|||Lefaucheur C,Viglietti D,Bentlejewski C,Duong van Huyen JP,Vernerey D,Aubert O,Verine J,Jouven X,Legendre C,Glotz D,Loupy A,Zeevi A, IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury. Journal of the American Society of Nephrology : JASN. 2016 Jan; [PubMed PMID: 26293822]|
|||Kurian SM,Williams AN,Gelbart T,Campbell D,Mondala TS,Head SR,Horvath S,Gaber L,Thompson R,Whisenant T,Lin W,Langfelder P,Robison EH,Schaffer RL,Fisher JS,Friedewald J,Flechner SM,Chan LK,Wiseman AC,Shidban H,Mendez R,Heilman R,Abecassis MM,Marsh CL,Salomon DR, Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2014 May; [PubMed PMID: 24725967]|
|||Roedder S,Sigdel T,Salomonis N,Hsieh S,Dai H,Bestard O,Metes D,Zeevi A,Gritsch A,Cheeseman J,Macedo C,Peddy R,Medeiros M,Vincenti F,Asher N,Salvatierra O,Shapiro R,Kirk A,Reed EF,Sarwal MM, The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study. PLoS medicine. 2014 Nov; [PubMed PMID: 25386950]|
|||Ghiyasvandian S,Zakerimoghadam M,Peyravi H, Nurse as a facilitator to professional communication: a qualitative study. Global journal of health science. 2014 Nov 16; [PubMed PMID: 25716406]|